Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
20195-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
Martin, L.M.; Möller, M.; Weiss, U.; Russe, O.Q.; Scholich, K.; Pierre, S.; Geisslinger, G.; Niederberger, E.
Journal Article
2017AMPK contributes to aerobic exercise-induced antinociception downstream of endocannabinoids
King-Himmelreich, T.S.; Möser, C.V.; Wolters, M.C.; Schmetzer, J.; Schreiber, Y.; Ferreirós, N.; Russe, O.Q.; Geisslinger, G.; Niederberger, E.
Journal Article
2015Activation of AMPK and its Impact on Exercise Capacity
Niederberger, E.; King, T.S.; Russe, O.Q.; Geisslinger, G.
Journal Article
2015AMP-activated protein kinase is activated by non-steroidal anti-inflammatory drugs
King, T.S.; Russe, O.Q.; Möser, C.V.; Ferreirós, N.; Kynast, K.L.; Knothe, C.; Olbrich, K.; Geisslinger, G.; Niederberger, E.
Journal Article
2015TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes
Möser, C.V.; Stephan, H.; Altenrath, K.; Kynast, K.L.; Russe, O.Q.; Olbrich, K.; Geisslinger, G.; Niederberger, E.
Journal Article
2014LPS inhibits caspase 3-dependent apoptosis in RAW264.7 macrophages induced by the AMPK activator AICAR
Russe, O.Q.; Möser, C.V.; Kynast, K.L.; King, T.S.; Olbrich, K.; Grösch, S.; Geisslinger, G.; Niederberger, E.
Journal Article
2013Activation of the AMP-Activated Protein Kinase Reduces Inflammatory Nociception
Russe, O.; Möser, C.; Kynast, K.; King, T.; Stephan, H.; Geisslinger, G.; Niederberger, E.
Journal Article
2013Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets
Kynast, K.; Russe, O.; Geisslinger, G.; Niederberger, E.
Journal Article
2012Modulation of central nervous system–specific microRNA‐124a alters the inflammatory response in the formalin test in mice
Kynast, K.; Russe, O.; Möser, C.; Geisslinger, G.; Niederberger, E.
Journal Article